US Stock MarketDetailed Quotes

BMRN Biomarin Pharmaceutical

Watchlist
  • 66.290
  • -2.090-3.06%
Trading Jan 10 11:19 ET
12.63BMarket Cap39.93P/E (TTM)

Biomarin Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2024/Q3
Stock NameRevenueRatio
Voxzogo189.79M25.45%
Vimizim178.16M23.89%
Naglazyme131.91M17.69%
Palynziq90.63M12.15%
ALDURAZYME71.03M9.52%
Brineura37.01M4.96%
Kuvan28.12M3.77%
Royalty and other revenues11.87M1.59%
ROCTAVIAN7.24M0.97%
View all
Region Currency:USD
2023/FY
Stock NameRevenueRatio
United States771.31M31.88%
Europe669.33M27.67%
Rest of world468.21M19.35%
Latin America332.44M13.74%
Aldurazyme net product revenues marketed by Sanofi131.25M5.43%
Royalty and other revenues46.69M1.93%
View all
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Petroleo Brasileiro SA Petrobras
PBR
+0.71%
Ecopetrol
EC
+0.41%
Meta Platforms
META
+0.43%
Vale SA
VALE
-0.35%
MicroStrategy
MSTR
-0.76%

Unlock the Full List